Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) "COGENT-1"


Phase 3 Results N/A

Summary of Purpose

The purpose of the COGENT-1 clinical trial is to determine whether CGT-2168 (clopidogrel and omeprazole) compared to clopidogrel is safe and effective in reducing the incidence of gastrointestinal bleeding and symptomatic ulcer disease, in the setting of concomitant aspirin therapy. Antiplatelet therapy is an... Trial Stopped: Terminated by Sponsor

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 January 2009.

1 Dec 2007 12 Nov 2007 1 Nov 2009 1 Nov 2009 1 Jan 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • Pablo Lapuerta, MD Phone: 650-543-4730